These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 525256)

  • 21. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation.
    Dempsey OJ; McGeoch P; de Silva RN; Douglas NJ
    Neurology; 2003 Aug; 61(4):537-40. PubMed ID: 12939432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mazindol: a new anorectic drug].
    Siani V
    Clin Ter; 1978 Jan; 84(1):100-1. PubMed ID: 630811
    [No Abstract]   [Full Text] [Related]  

  • 25. Mazindol: a risk factor for pulmonary arterial hypertension?
    Konofal E; Benzouid C; Delclaux C; Lecendreux M; Hussey E
    Sleep Med; 2017 Jun; 34():168-169. PubMed ID: 28522087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
    Enzi G; Baritussio A; Marchiori E; Crepaldi G
    J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058
    [No Abstract]   [Full Text] [Related]  

  • 29. Mazindol: its efficacy and mode of action in generating weight loss.
    Johnson WG; Hughes JR
    Addict Behav; 1979; 4(3):237-44. PubMed ID: 495247
    [No Abstract]   [Full Text] [Related]  

  • 30. Mazindol in Duchenne muscular dystrophy.
    Coakley JH; Edwards RH; Moorcraft J; Hipkin LJ; Smith CS
    Lancet; 1988 Jan; 1(8578):184. PubMed ID: 2893022
    [No Abstract]   [Full Text] [Related]  

  • 31. [Overweight as a therapeutic problem. Experience with the appetite depressant Mazindol].
    Linke H
    Med Welt; 1976 Oct; 27(42):2021-5. PubMed ID: 792620
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
    Husmann F
    Med Welt; 1976 Oct; 27(40):1904-8. PubMed ID: 790077
    [No Abstract]   [Full Text] [Related]  

  • 33. Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
    Zatz M; Rapaport D; Pavanello RC; Rocha JM; Vainzof M; Nicolau W
    Am J Med Genet; 1989 Aug; 33(4):457-67. PubMed ID: 2596504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind evaluation of mazindol in refractory obesity.
    Smith RG; Innes JA; Munro JF
    Br Med J; 1975 Aug; 3(5978):284. PubMed ID: 1097046
    [No Abstract]   [Full Text] [Related]  

  • 35. Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
    Parkes JD; Fenton GW
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):1076-81. PubMed ID: 4359162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR; Ballard IM; Gold JA
    J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mazindol in the treatment of Parkinson's disease.
    Delwaide PJ; Martinelli P; Schoenen J
    Arch Neurol; 1983 Dec; 40(13):788-90. PubMed ID: 6357158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history, symptoms and treatment of the narcoleptic syndrome.
    Parkes JD; Baraitser M; Marsden CD; Asselman P
    Acta Neurol Scand; 1975 Nov; 52(5):337-53. PubMed ID: 19899267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind cross-over evaluation of mazindol in the treatment of obese hypertensive patients.
    Miach PJ; Thomson W; Doyle AE; Louis WJ
    Med J Aust; 1976 Sep; 2(10):378-80. PubMed ID: 792640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.